The Biologics Market is poised for substantial transformation, with projections indicating a remarkable leap from USD 358.3 billion in 2024 to a staggering USD 3,338.29 billion by 2035. This impressive forecast is underpinned by a compound annual growth rate (CAGR) of 4.54%. The demand for biologics, characterized by their effectiveness in treating complex diseases, is surging, driven by an...